SBRT vs Conventional Radiation — Fewer, Stronger Sittings
Medically reviewed by Dr. Venkata Sushma P, Radiation Oncologist, MBBS · MD (Radiation Oncology) · Last reviewed August 2026
Conventional radiation delivers a lower dose across 25 to 30 daily sessions spread over several weeks. Stereotactic Body Radiotherapy (SBRT) uses high-precision imaging and immobilisation to deliver the same biological effect in just 3 to 5 stronger sessions — for tumours where size, location and imaging accuracy make that precision possible. SBRT isn't a shortcut or an upgrade everyone qualifies for; it's a different targeting approach suited to specific anatomy.
- Fewer sittings isn't a lesser course — SBRT's higher dose per session is calculated to match or exceed a full conventional course's total effect, not a shortcut.
- Eligibility comes first — SBRT suits small, well-defined tumours at a limited number of sites; your scans, not your preference, decide if you qualify.
- Precision replaces margin — high-resolution imaging and tight immobilisation let a stronger dose land on target while sparing healthy tissue around it.
- Delivered at NABH-accredited partner centres — CION doesn't own the equipment; we coordinate your treatment plan, your oncology team and your care throughout.
on Panel
Telangana & AP
Treated
(800+ reviews)
Why does SBRT need only 3-5 sittings instead of 25-30?
SBRT delivers a much higher dose per session than conventional radiation, so the same total biological effect is reached in 3 to 5 visits instead of 25 to 30. High-resolution imaging and tight immobilisation let that stronger dose land precisely on the tumour each time, which is what makes fewer, stronger sessions possible in the first place.
Conventional radiation instead spreads a lower dose across many sessions, giving healthy tissue time to recover between visits — a strategy that suits larger or less clearly defined tumours, or sites where SBRT's precision requirements can't be met. Neither approach is inherently stronger; each is matched to what a specific tumour's size, location and imaging characteristics allow.
The sections below cover safety, a side-by-side comparison, and the eligibility criteria that actually decide whether SBRT applies to your case.
Did you know?
SBRT relies on imaging accuracy tight enough to track a tumour’s position to within a few millimetres between and during sessions — a level of precision conventional radiation planning does not require, per ASTRO patient-education materials current as of 2026.
Is a bigger dose per session more dangerous?
Not inherently — the risk depends on how precisely that dose is aimed, not its size alone. SBRT is used only where imaging can define a tumour's edges clearly enough, and immobilisation can hold it still enough, for a strong dose to land on target every session while sparing the tissue around it.
NCCN and ASTRO both describe SBRT as a well-established, guideline-supported option for eligible tumours — not a riskier shortcut. Where a tumour moves with breathing, sits close to several critical organs, or can't be imaged with enough precision, your team will recommend conventional fractionation instead, because that is what keeps a strong dose safe for that specific anatomy.
Ask your radiation oncologist what makes your specific tumour precise enough — or not — to track for SBRT; that answer matters more than the general question of dose size.
SBRT vs Conventional Radiation — Side by Side
A quick comparison to bring into your own consult. Every row is a question worth asking your radiation oncologist directly about your specific plan.
| Factor | Conventional radiation | SBRT |
|---|---|---|
| Typical number of sessions | 25-30 sessions over 5-6 weeks | 3-5 sessions over 1-2 weeks |
| Dose per session | Lower, spread across many visits | Much higher, concentrated per visit |
| Imaging & immobilisation | Standard planning CT and setup | High-resolution imaging + tight immobilisation each session |
| Typical tumour size / site fit | Larger or less clearly defined targets, wider fields | Small (commonly under ~5cm), well-defined, limited sites |
| Healthy-tissue margin | Wider margin; dose spread lowers per-visit risk | Steep dose fall-off needed to protect nearby tissue |
| Where it's commonly used | Most cancers, large or diffuse fields, many curative & palliative courses | Early-stage lung, liver, spine, oligometastatic disease |
| Guideline standing | Standard, guideline-supported (NCCN / ASTRO) | Standard, guideline-supported (NCCN / ASTRO) for eligible cases |
| Cost pattern (indicative only, as of August 2026) | Lower per session, more sessions overall | Higher per session, fewer sessions overall |
| Is one technique "stronger"? | Neither, in general — the right technique depends on tumour size, site and how precisely it can be targeted | |
This table is a starting framework, not a diagnosis. Your own experience depends on your cancer type, treatment site, dose and overall health — ask your radiation oncologist how these rows apply to your specific plan.
Am I eligible for SBRT?
Eligibility depends on your tumour's size, number, location and how precisely it can be imaged and immobilised — not on how advanced your cancer sounds. Most searchers want this answer more than the physics behind it, so here's what your team actually checks before recommending SBRT.
- Tumour size — generally under about 5 cm, though your team assesses your specific case on imaging.
- Number of tumour sites — SBRT suits a single tumour or a small, limited number of sites (oligometastatic disease).
- Tumour location — clearly defined on imaging, with enough distance from multiple critical organs.
- Tumour stability — the tumour and surrounding anatomy can be immobilised reliably session to session.
- Common qualifying diagnoses — early-stage lung cancer, liver tumours, spine metastases, some oligometastatic cases.
- Overall fitness — general health to tolerate the setup and immobilisation required each session.
If even one of these doesn't fit your case, that doesn't mean your cancer is being under-treated — it means conventional fractionation is the technique that better fits your tumour's anatomy. Your radiation oncologist confirms eligibility only after reviewing your scans directly.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer on whether SBRT fits your case
A radiation oncologist can review your scans and explain plainly whether SBRT's eligibility criteria apply to you — free, confidential, no commitment to start treatment.
Where does SBRT genuinely fit — and where is conventional radiation the right call?
"SBRT vs conventional radiation" as a general question has no single winner. These are the specific situations that actually decide it.
Early-stage lung cancer (inoperable)
A small, well-defined lung tumour that can be tracked with breath-hold or gating imaging is one of the best-established SBRT indications.
Liver tumours, limited in number
A small number of liver lesions, clearly seen on imaging and at a safe distance from major vessels, is a common SBRT application.
Spine metastases
SBRT can deliver a high, precise dose to a spinal lesion while respecting the spinal cord's dose tolerance limit.
Oligometastatic disease
Where imaging shows a small number of metastases rather than widespread disease, SBRT can target each site individually.
Large or diffuse tumours
Where disease spans a wide field, spreading a lower dose over more sessions protects the surrounding tissue better.
Tumours close to multiple organs
When several critical organs crowd the target, the steep dose fall-off SBRT depends on may not be achievable safely.
How does your treatment team decide between SBRT and conventional radiation?
Your radiation oncologist reviews your imaging to check tumour size, number of sites, how close it sits to critical organs, and whether it can be tracked reliably with imaging and immobilisation session to session. If those criteria fit, SBRT is planned to deliver the same total effect in fewer, stronger visits. If they don't, conventional fractionation is planned — not as a fallback, but because it's the technique that suits your tumour's anatomy.
If you're supporting a parent or relative through this decision and worried that fewer sessions means a lighter course of treatment, that fear is understandable but not accurate here: SBRT's dose per session is calculated to match or exceed a full conventional course for tumours that qualify. A tumour board reviews every case before treatment starts, and you're welcome to ask the team directly why a particular technique was chosen for your relative's case.
Whichever technique fits, your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.
Questions worth asking before you accept either technique
A short list to take into your own appointment — your team's answers, not this page, should guide your decision.
- Does my tumour meet the size and site criteria for SBRT? — this is the single question that decides eligibility, not preference.
- What specific imaging confirms my tumour can be tracked precisely? — ask what's actually being checked, not just a yes or no.
- Is conventional radiation an equally effective option for my diagnosis? — worth asking directly, even if SBRT was already recommended.
- What is the written, itemised cost for each approach? — get both figures in writing, indicative as of August 2026.
- Which NABH-accredited partner centre will deliver my sessions? — confirm where treatment is actually delivered.
One conversation usually settles whether SBRT is right for you
Whether you're comparing two treatment plans or already have one on the table, a radiation oncologist can walk you through exactly why a technique was chosen for your case.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.SBRT vs Conventional Radiation — your questions answered
Why does SBRT need only 3-5 sittings instead of 25-30?
SBRT delivers a much higher dose per session than conventional radiation, so the same total biological effect is reached in far fewer visits — typically 3 to 5 sessions instead of 25 to 30. High-resolution imaging and tight immobilisation let that stronger dose land precisely on the tumour each time, which is what makes fewer, stronger sessions possible. Conventional radiation instead spreads a lower dose across many sessions, giving healthy tissue time to recover between visits — a different, equally valid strategy suited to larger or less clearly defined targets that don't meet SBRT's precision requirements.
Is a bigger dose per session more dangerous than smaller doses?
Not inherently — the risk from a larger per-session dose depends on how precisely it is aimed, not the dose size alone. SBRT is only used where imaging can define the tumour's edges clearly and immobilisation can keep it still enough that the high dose lands on target every session; NCCN and ASTRO both describe SBRT as a well-established option for eligible cases, not an inherently riskier one. Where a tumour moves with breathing, sits close to several critical organs, or can't be imaged precisely enough, your team will choose conventional fractionation instead, because the safety of a bigger dose depends entirely on targeting accuracy for your specific anatomy.
Am I eligible for SBRT? What determines eligibility?
Eligibility depends mainly on tumour size, number, location and how well it can be imaged and immobilised — not on how advanced your cancer sounds. SBRT is generally considered for small, well-defined tumours (commonly under about 5 cm), a limited number of sites such as early-stage lung cancer, liver tumours, spine metastases or oligometastatic disease, and cases where the target can be tracked reliably and stays still enough between and during sessions. Large, diffuse, or hard-to-immobilise tumours, or those very close to multiple critical organs, are usually better suited to conventional fractionation. Only your radiation oncologist, after reviewing your scans, can confirm whether your specific case qualifies.
Does fewer sessions mean I'm getting less treatment?
No — fewer sessions with SBRT does not mean a smaller or weaker course of treatment. Each SBRT session delivers a much higher dose, so the total biological effect over 3 to 5 sessions is calculated to match or exceed what conventional radiation achieves over 25 to 30 sessions for an eligible tumour. The number of visits reflects the technique's precision, not the seriousness with which your case is being treated. If SBRT has been recommended for you, it is because your tumour's size, location and imaging characteristics fit the criteria — not because your team is taking a shortcut.
Is SBRT the same as SRS or CyberKnife?
They're closely related but not identical terms. SRS (Stereotactic Radiosurgery) refers to this same high-precision, few-session approach when used specifically for brain and spine targets; SBRT is the term used when the same principle is applied to body sites such as the lung, liver or bone. CyberKnife is one specific machine — a robotic delivery system — that can be used to deliver either SRS or SBRT; it's a brand of equipment, not a separate technique. So SBRT describes what is being done (few, high-dose, image-guided sessions to a body target), while CyberKnife describes one possible device used to deliver it.
How much does SBRT cost compared to conventional radiation?
SBRT's per-session cost is typically higher than a conventional fraction because of the additional imaging, planning and quality-assurance work each session requires, but the much smaller number of sessions can bring the overall course cost closer to, and sometimes below, a full conventional course — figures are indicative only, as of August 2026, and vary by centre and treatment site. Ask your care team for a written, itemised estimate for both approaches where either is genuinely appropriate for your diagnosis, so you can compare the real total cost rather than just the per-session figure.
This page compares SBRT and conventional radiation in general terms; it is not a substitute for guidance from your own radiation oncology team about your specific diagnosis, anatomy and treatment plan.